Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03180398 · ClinicalTrials.gov registry record · NA
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
A NA study, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03180398 is a NA study that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 9 participants.
The verdict
NCT03180398, a NA study, was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a pilot study of implement multi-parametric MR imaging for organ delineation and tumor response assessment of prostate cancer patients being treated with radiation therapy.
Interventions
- DEVICE Multiparametric MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-10-04 |
| Est. Completion | 2022-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03180398
The ClinicalTrials.gov registry entry for NCT03180398 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multiparametric MRI is the first listed.
NCT03180398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03180398 about?
NCT03180398 is a clinical study titled "Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients". This is a pilot study of implement multi-parametric MR imaging for organ delineation and tumor response assessment of prostate cancer patients being treated with radiation therapy.
What is the current status of trial NCT03180398?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2017-10-04. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT03180398?
The interventions under investigation include: Multiparametric MRI (DEVICE).
Who is sponsoring clinical trial NCT03180398?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.